MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC
Clinical trial NCT07331428 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07331428
- Sponsor
- Fujian Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2027-12-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.